Home
News
Screeners
Insights
Modern Diagnostic & Research Centre
65.
00
+4.16
(+6.84%)
Market Cap
₹98.18 Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+6.84%
1M
+25.00%
6M
-3.63%
1Y
0.00%
5Y
0.00%
View Company Insights
Latest news about Modern Diagnostic & Research Centre
Modern Diagnostic revenue up 7% in FY26; PAT falls 42% to ₹52.5 crore
5 days ago
Operating income rose 6.6% YoY to ₹8,311.06 lakh in FY26. Profit after tax fell 41.7% to ₹525.33 lakh amid higher expenses. EBITDA margin contracted to 16.18% from 24.00% in FY25. 14th AGM scheduled for September 30, 2026, to approve financials. Company launched five new labs and expanded specialized diagnostics.
Modern Diagnostic schedules board meeting on Sep 3 to approve AGM notice
Aug 26, 2026
Modern Diagnostic FY26 net profit falls 42% to ₹525.33 lakh
May 29, 2026
Board to consider Q4FY26 results on May 29
May 21, 2026
Promoters hold 72.85% stake in Modern Diagnostic
May 21, 2026
More news about Modern Diagnostic & Research Centre
13
May 26
Modern Diagnostic & Research Centre Board Approves Extension of IPO Proceeds Utilization and Working Capital Allocation
Modern Diagnostic & Research Centre Limited held a Board of Directors meeting on May 13, 2026, approving an extension of time for the utilization of net issue proceeds and project completion as per the prospectus. The board also approved the use of General Corporate Purpose funds for working capital requirements. Additionally, the board discussed temporary faults in the company's hardware and software systems, which caused brief shutdowns that were subsequently restored. The disclosures were made in compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
16
Apr 26
Modern Diagnostic and Research Centre Limited Clarifies Significant Price Movement to BSE
Modern Diagnostic and Research Centre Limited responded to BSE's inquiry about significant price movement in its securities on April 9, 2026. The company clarified that there is no undisclosed price-sensitive information or pending announcements affecting the stock price. Management attributed the price fluctuations to market conditions and confirmed full compliance with SEBI regulations, assuring continued prompt disclosure of material events.
Modern Diagnostic & Research Centre
65.
00
+
4.
16
(+
6.
84
%)
1 Year Returns:
0.00%
Industry Peers
Dr. Lal Path Labs
1,916.70
(-
0.
16
%)
Vijaya Diagnostic Centre
1,498.80
(-
0.
01
%)
Metropolis Healthcare
595.65
(-
1.
07
%)
Thyrocare Technologies
557.70
(-
1.
61
%)
Nephrocare Health Services
747.25
(+
1.
88
%)
Krsnaa Diagnostics
564.40
(+
0.
62
%)
Suraksha Diagnostic
327.85
(-
2.
32
%)
3B BlackBio DX
1,443.30
(-
2.
22
%)
One Global Service Provider
546.00
(+
1.
04
%)
Health X Platform
305.35
(+
1.
95
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar